11/13
08:53 am
lvtx
LAVA intents to delist from Nasdaq [Seeking Alpha]
Low
Report
LAVA intents to delist from Nasdaq [Seeking Alpha]
11/13
07:30 am
lvtx
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq
Low
Report
LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq
11/12
08:21 am
lvtx
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
Neutral
Report
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
11/12
07:47 am
lvtx
XOMA GAAP EPS of $0.70 beats by $0.74, revenue of $9.35M misses by $2.12M [Seeking Alpha]
Neutral
Report
XOMA GAAP EPS of $0.70 beats by $0.74, revenue of $9.35M misses by $2.12M [Seeking Alpha]
11/10
04:38 pm
lvtx
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline [Yahoo! Finance]
Low
Report
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline [Yahoo! Finance]
11/10
04:09 pm
lvtx
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
Neutral
Report
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
10/20
12:58 pm
lvtx
Shareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement
Low
Report
Shareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement